Skip to content

Multi-center Study on Comprehensive Diagnosis and Treatment of Lower Limb Bone Defect Based on Three-dimensional Printing Technology

Multi-center Study on Comprehensive Diagnosis and Treatment of Lower Limb Bone Defect Based on Three-dimensional Printing Technology

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06269354
Enrollment
120
Registered
2024-02-21
Start date
2023-11-01
Completion date
2026-12-31
Last updated
2024-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Defects

Keywords

3D printing technology; bone defects; clinical effects

Brief summary

The clinical diagnosis and treatment of lower limb bone defect is a difficult problem in orthopedics. The traditional treatment has the shortcomings of long treatment period, no weight bearing in the early stage of the limb, weak mechanical strength, many complications, and difficulty in repairing deformed and large segment bone defects around the joint. The Orthopedics Department of Peking University Third Hospital, the lead unit of this study, developed the TCBridge system based on three-dimensional (3D) printing technology in the early stage, which is the first approved 3D printing lower limb long bone defect repair system in China. The system can achieve personalized and accurate repair of lower limb bone defects, and ensure patients to carry out limb weight and functional exercise safely in the early stage after surgery. On this basis, this study will establish a multi-center clinical case cohort to achieve accurate comprehensive diagnosis and treatment of lower limb bone defects, benefiting patients and contributing to society.

Interventions

DEVICE3D printed prostheses

3D printed prostheses

Sponsors

Peking University Third Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. Patients with traumatic lower limb bone defect; 2. Infected lower limb bone defect patients; 3. Patients with neoplastic lower limb bone defect; 4. The above reasons caused bone defects of more than 5CM 5. at least 18 years of age; 6. Sign an informed agreement and join the study cohort voluntarily.

Exclusion criteria

1. Patients who do not agree to the use of 3D printed microporous titanium alloy prostheses; 2. Patients who cannot tolerate surgery; 3. the subjects cannot comply with the follow-up or affect the scientific and integrity of the study; 4. Other patients who were not suitable for inclusion as assessed by clinicians.

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of implant stability, new bone growth- limb lengthpost-operative 1.3.6.12.24.36 monthsX-ray X、CT images
Evaluation of bone healingpost-operative 3.6.12.24.36 monthscomputed tomography (CT)

Secondary

MeasureTime frameDescription
Evaluation of knee functionpost-operative 1.3.6.12.24.36 monthshospital for special surgery (HSS) score. The maximum score of HSS is 100, higher score represents better result.
Pain assessmentpost-operative 1.3.6.12.24.36 monthsVisual Analog Score (VAS), total score is 10, 0 represents no pain, 10 represents the most unbearable pain
Evaluation of ankle functionpost-operative 1.3.6.12.24.36 monthsAmerican Orthopaedic Foot & Ankle Society (AOFAS) score,The maximum score of AOFAS score is 100, higher score represents better result.
Evaluation of hip functionpost-operative 1.3.6.12.24.36 monthsHarris score, The maximum score of Harris score is 100, higher score represents better result.
Evaluation of life quality and health status.post-operative 1.3.6.12.24.36 months36-item short form survery (SF-36) questionnaire, it includes 8 itmem, namely physical functioning, vitality, bodily pain, general health, social functioning, role physical, role emotional, mental health. The maximum score of each item is 100, higher score represents better result.

Countries

China

Contacts

Primary ContactBingchuan Liu, Doctor
liubc@bjmu.edu.cn+86 18310188678

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026